Metabolic Syndrome in Patients With Ankylosing Spondylitis

Ibrahim Batmaz, Mehmet Karakoc, Mustafa Akif Sariyildiz, Selma Yazici, Mehmet Tahtasiz, Zuhal Atilgan, Remzi Cevik, Kemal Nas


Background: The objective of this study is to investigate the presence of metabolic syndrome (MS) in patients with ankylosing spondylitis (AS) and to evaluate its relationship with the clinical parameters.

Methods: Fifty patients who presented to the Dicle University School of Medicine, Physical Therapy and Rehabilitation Outpatient Clinic and were diagnosed with AS according to the 1984 New York criteria were enrolled in this study. The control group consisted of 44 healthy control subjects. Assessment of the MS was made according to the diagnostic criteria specified in the National Cholesterol Education Program Adult Treatment Panel III Report (NCEP ATP III). Functional status and disease activity were evaluated using the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for AS.

Results: MS was observed in 6 out of the 50 AS patients (12%) and in 2 out of the 44 controls (4.5%) (P > 0.05). However, the HDL cholesterol level (P = 0.006) was found as significantly lower in AS patients than the controls. No statistically significant differences were observed in the disease duration and functional and clinical activity indices between the AS patients with and without MS.

Conclusion: Although the frequency of MS was observed to be higher in patients with AS than the controls in this study, the differences were statistically insignificant between the two groups.

J Endocrinol Metab. 2011;1(5):215-219


Ankylosing spondylitis; Metabolic syndrome†

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.